HuagongsheHuagongshe Chemistry Print Report · For research reference only
{2-[4-(3-Chloro-4-fluoro-phenylamino)-quinazolin-6-ylcarbamoyl]-ethyl}-carbamic acid t-butylester → Allitinib metabolite M6
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | {2-[4-(3-Chloro-4-fluoro-phenylamino)-quinazolin-6-ylcarbamoyl]-ethyl}-carbamic acid t-butylester | HCID 11698299 | — |
| Reactant | 3-Amino-N-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)propanamide | HCID 67334123 | — |
| Product | Allitinib metabolite M6 | HCID 53630477 | — |
Reaction Steps
The procedure of (20-1) of Example 20 was repeated except for using 0.55 g of the compound obtained in Example 52 instead of the compound obtained in (1-4) of Example 1 to obtain the title compound (0.4 g, 93%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08003658B2 |
| Source dataset | uspto-grants-2011_08 |
| ORD ID | ord-d0ffda55ee0642fc8934c5fb7c604e16 |
| Source note | uspto-grants-2011_08 |